PDPN and cancer: They verified the roles of tumour growth promoter CAFs and podoplanin positivity in promoting cancer cell proliferation and evaluated the MIB-1 index by comparing podoplanin (+) and podoplanin (−) cancer cells in both groups (Nakamura et al., 2019).